Work

Mesenchymal drift in skeletal muscle drives bone loss via secretome remodeling and is attenuated by partial reprogramming

Year: 2026
Type: preprint
Abstract: Aging is an intricate systemic process profoundly influenced by inter-organ communication, where skeletal muscle functions as a major endocrine hub. Here, we identify mesenchymal drift (MD) as a conserved transcriptomic and structural hallmark of aged skeletal muscle across human and mice cohorts. MD drives a hyper-secretory phenotype, triggering the excessive release of pro-inflammatory myokines and extracellular vesicles (EVs). Localized in vivo partial reprogramming (OSK) of aged muscle successfully attenuates local MD, rejuvenates the aberrant secretome, restores skeletal muscle mass and function, rescues age-related bone loss, and partially alleviates aging phenotypes in a subset of distant organs. Through functional add-back interventions, we mechanistically decouple cell-autonomous muscle rejuvenation from the secretome-dependent partial amelioration of distant organ senescence. Furthermore, single-cell transcriptomics and in vivo profiling pinpoint an expanding subpopulation of EGFR⁺ fibro-adipogenic progenitors (FAPs) as the principal cellular drivers of both MD and the aging secretome. Finally, utilizing engineered anti-PDGFRα-targeted lipid nanoparticles (LNPs) to deliver OSK mRNA or EGFR siRNA exclusively to FAPs, we successfully suppress the hyper-secretory phenotype, reverse osteoporotic decline, and partly mitigate distal organ aging. Together, our findings establish MD-driven secretome remodeling as a pivotal governor of systemic aging and present a highly translatable, FAP-targeted nanomedical strategy for organismal rejuvenation.
Language: English
Open Access status: green
OpenAlex ID: W7236773618
Cites: 72
Cited by:
Related to: 10